403 related articles for article (PubMed ID: 33928026)
21. A new risk model based on a 11-m
Lei L; Li N; Yuan P; Liu D
BMC Cancer; 2022 Apr; 22(1):365. PubMed ID: 35382776
[TBL] [Abstract][Full Text] [Related]
22. Identification of a robust signature for clinical outcomes and immunotherapy response in gastric cancer: based on N6-methyladenosine related long noncoding RNAs.
Han T; Xu D; Zhu J; Li J; Liu L; Deng Y
Cancer Cell Int; 2021 Aug; 21(1):432. PubMed ID: 34399770
[TBL] [Abstract][Full Text] [Related]
23. N6-Methyladenosine-Related lncRNAs Are Novel Prognostic Markers and Predict the Immune Landscape in Acute Myeloid Leukemia.
Zhang L; Ke W; Hu P; Li Z; Geng W; Guo Y; Song B; Jiang H; Zhang X; Wan C
Front Genet; 2022; 13():804614. PubMed ID: 35615374
[No Abstract] [Full Text] [Related]
24. Identification of m6A-Related lncRNAs Associated With Prognoses and Immune Responses in Acute Myeloid Leukemia.
Li D; Liang J; Cheng C; Guo W; Li S; Song W; Song Z; Bai Y; Zhang Y; Wu X; Zhang W
Front Cell Dev Biol; 2021; 9():770451. PubMed ID: 34869365
[No Abstract] [Full Text] [Related]
25. m6A-Related lncRNA Signature Is Involved in Immunosuppression and Predicts the Patient Prognosis of the Age-Associated Ovarian Cancer.
Li M; Zhang L; Feng M; Huang X
J Immunol Res; 2022; 2022():3258400. PubMed ID: 35991123
[TBL] [Abstract][Full Text] [Related]
26. N6-Methylandenosine-Related lncRNA Signature Is a Novel Biomarkers of Prognosis and Immune Response in Colon Adenocarcinoma Patients.
Zhang P; Liu G; Lu L
Front Cell Dev Biol; 2021; 9():703629. PubMed ID: 34336856
[TBL] [Abstract][Full Text] [Related]
27. m6A-Related lncRNA to Develop Prognostic Signature and Predict the Immune Landscape in Bladder Cancer.
Li Z; Li Y; Zhong W; Huang P
J Oncol; 2021; 2021():7488188. PubMed ID: 34349798
[TBL] [Abstract][Full Text] [Related]
28. Expression Status And Prognostic Value Of M6A-associated Genes in Gastric Cancer.
Guan K; Liu X; Li J; Ding Y; Li J; Cui G; Cui X; Sun R
J Cancer; 2020; 11(10):3027-3040. PubMed ID: 32226518
[No Abstract] [Full Text] [Related]
29. Comprehensive Analysis and Prognosis Prediction of N6-Methyladenosine-Related lncRNAs in Immune Microenvironment Infiltration of Gastric Cancer.
Huang J; Chen W; Chen C; Jie Z; Xiao T
Int J Gen Med; 2022; 15():2629-2643. PubMed ID: 35300127
[TBL] [Abstract][Full Text] [Related]
30. Identification of N6-Methyladenosine-Related LncRNAs for Predicting Overall Survival and Clustering of a Potentially Novel Molecular Subtype of Breast Cancer.
Zhong X; Li J; Wu X; Wu X; Hu L; Ding B; Qian L
Front Oncol; 2021; 11():742944. PubMed ID: 34722294
[TBL] [Abstract][Full Text] [Related]
31. N6-Methylandenosine-Related lncRNAs Are Potential Biomarkers for Predicting the Overall Survival of Lower-Grade Glioma Patients.
Tu Z; Wu L; Wang P; Hu Q; Tao C; Li K; Huang K; Zhu X
Front Cell Dev Biol; 2020; 8():642. PubMed ID: 32793593
[TBL] [Abstract][Full Text] [Related]
32. Identification of a 14-lncRNA Signature and Construction of a Prognostic Nomogram Predicting Overall Survival of Gastric Cancer.
Nie K; Deng Z; Zheng Z; Wen Y; Pan J; Jiang X; Yan Y; Liu P; Liu F; Li P
DNA Cell Biol; 2020 Sep; 39(9):1532-1544. PubMed ID: 32644844
[TBL] [Abstract][Full Text] [Related]
33. Identification and Validation of a Novel 2-LncRNAs Signature Associated with m6A Regulation in Colorectal Cancer.
Wang K; Zhao B; Liang Y; Ma B
J Cancer; 2022; 13(1):21-33. PubMed ID: 34976168
[TBL] [Abstract][Full Text] [Related]
34. The Role of Critical N6-Methyladenosine-Related Long Non-Coding RNAs and Their Correlations with Immune Checkpoints in Renal Clear Cell Carcinoma.
Deng W; Wang G; Deng H; Yan Y; Zhu K; Chen R; Liu X; Chen L; Zeng T; Fu B
Int J Gen Med; 2021; 14():9773-9787. PubMed ID: 34934351
[TBL] [Abstract][Full Text] [Related]
35. A Prognostic Signature for Colon Adenocarcinoma Patients Based on m6A-Related lncRNAs.
Zhou SZ; Pan YL; Deng QC; Yin CJ; Zhou DJ; Liu ML; Zhou J; Wu XJ
J Oncol; 2023; 2023():7797710. PubMed ID: 36814559
[TBL] [Abstract][Full Text] [Related]
36. Identification and Validation of m6A-Related lncRNA Signature as Potential Predictive Biomarkers in Breast Cancer.
Lv W; Wang Y; Zhao C; Tan Y; Xiong M; Yi Y; He X; Ren Y; Wu Y; Zhang Q
Front Oncol; 2021; 11():745719. PubMed ID: 34722303
[TBL] [Abstract][Full Text] [Related]
37. Prognostic and Predictive Value of m6A "Eraser" Related Gene Signature in Gastric Cancer.
Xu X; Zhou E; Zheng J; Zhang C; Zou Y; Lin J; Yu J
Front Oncol; 2021; 11():631803. PubMed ID: 33718213
[TBL] [Abstract][Full Text] [Related]
38. m6A-related lncRNAs are potential biomarkers for the prognosis of COAD patients.
Xu C; He T; Shao X; Gao L; Cao L
Front Oncol; 2022; 12():920023. PubMed ID: 36119534
[TBL] [Abstract][Full Text] [Related]
39. N6-Methyladenosine-Related lncRNAs Are Potential Prognostic Biomarkers and Correlated With Tumor Immune Microenvironment in Osteosarcoma.
Zheng D; Yu L; Wei Z; Xia K; Guo W
Front Genet; 2021; 12():805607. PubMed ID: 35186011
[TBL] [Abstract][Full Text] [Related]
40. Expression Pattern and Prognostic Value of Key Regulators for m6A RNA Modification in Hepatocellular Carcinoma.
Zhang L; Qiao Y; Huang J; Wan D; Zhou L; Lin S; Zheng S
Front Med (Lausanne); 2020; 7():556. PubMed ID: 33072775
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
